ERMA — Enorama Pharma AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK172.00m
- SEK169.92m
- SEK15.77m
Annual cashflow statement for Enorama Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | — | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -23 | -26.9 | -41.5 | -42.1 | -47.5 |
| Depreciation | |||||
| Changes in Working Capital | -0.309 | -4.61 | 4.97 | -2.77 | -8.6 |
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -23 | -30.2 | -33 | -41.3 | -35.7 |
| Capital Expenditures | -3.84 | -1.82 | 0 | 0 | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | 0 | 0 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3.84 | -1.82 | 0 | 0 | 0 |
| Financing Cash Flow Items | — | -1.79 | -1.57 | 12 | -4.68 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 17 | 39.5 | 25.3 | 41.9 | 35.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -9.87 | 7.47 | -8.06 | 2.01 | -4.07 |